Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...

詳細記述

書誌詳細
主要な著者: Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A
フォーマット: Journal article
出版事項: Nature Publishing Group 2017

類似資料